1-3 of 3
H. Schmid
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination of Grading and New Biological Factors (S-Phase Fraction and Epidermal Growth Factor Receptor) Can Predict Relapse and Survival in Patients with Node-Negative Primary Breast Cancer

Available to Purchase
Subject Area:
Oncology
M. Kaufmann, G.v. Minckwitz, H.P. Finn, H. Schmid, K. Goerttler, G. Bastert
Journal: Onkologie
Onkologie (1994) 17 (2): 166–172.
https://doi.org/10.1159/000218403
Published Online: 11 May 2009
View articletitled, Combination of Grading and New Biological Factors (S-Phase Fraction and Epidermal Growth Factor Receptor) Can Predict Relapse and Survival in Patients with Node-Negative Primary Breast Cancer
Open the PDF for Combination of Grading and New Biological Factors (S-Phase Fraction and Epidermal Growth Factor Receptor) Can Predict Relapse and Survival in Patients with Node-Negative Primary Breast Cancer in another window
Journal Articles

Angiosarcoma of the Breast

Available to Purchase
Subject Area:
Oncology
K. Pohlodek, G. Leppien, H. Schmid, M. Kaufmann
Journal: Onkologie
Onkologie (1994) 17 (3): 242–247.
https://doi.org/10.1159/000218420
Published Online: 11 May 2009
View articletitled, Angiosarcoma of the Breast
Open the PDF for Angiosarcoma of the Breast in another window
Journal Articles

Prospective Randomized Trial Concerning Hyper- and Normoprolactinemia and the Use of Bromoergocryptine in Patients with Metastatic Breast Cancer

Available to Purchase
Subject Area:
Oncology
D. Fritze, W. Queißer, H. Schmid, M. Kaufmann, B. Massner, M. Westerhausen, R. Schmidt, L. Edler, U. Abel
Journal: Onkologie
Onkologie (1986) 9 (6): 305–312.
https://doi.org/10.1159/000216041
Published Online: 24 April 2009
View articletitled, Prospective Randomized Trial Concerning Hyper- and Normoprolactinemia and the Use of Bromoergocryptine in Patients with Metastatic Breast Cancer
Open the PDF for Prospective Randomized Trial Concerning Hyper- and Normoprolactinemia and the Use of Bromoergocryptine in Patients with Metastatic Breast Cancer in another window